No Data
Bullish market stimulation boosts Hong Kong healthcare stocks, causing Lai Kai Pharmaceuticals to surge over 18%.
①What bullish news about pharmaceutical stocks has recently been announced in the market? ②How do institutions view the subsequent performance of pharmaceutical stocks?
Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation
①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.
Stocks are hitting the ceiling! Since October, 10 A-share listed companies have announced being targeted, with china national medicines corporation and sh pharma being targeted on the same day by new china life insurance.
① According to incomplete statistics, since October, 10 A-share listed companies including zhejiang east crystal electronic, semiconductor manufacturing international corporation, quanjinhao, lifecome biochemistry, zhejiang jingu, primeton information technologies, inc., guangzhou goaland energy conservation tech, xuzhou handler special vehicle, china national medicines corporation, and sh pharma have announced that they have received major stock purchases from relevant parties (see attached table). ② In the secondary market, this week, xuzhou handler special vehicle and guangzhou goaland energy conservation tech have both seen their stock prices increase by more than 100% since September.
Are Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Investors Paying Above The Intrinsic Value?
November 14 Insurance Daily | Changes in the insurance industry for a "good start" in 2025, new china life insurance increased shareholding and simultaneously announced shareholding in sh pharma and china national medicines corporation.
The insurance industry's "New Year's kick-off" in 2025 has changed: some companies have cautiously promoted the "New Year's kick-off" and dividend insurance has become the main product of the industry. "New Year's kick-off" has become a characteristic and tradition of the insurance industry. At the end of each year and the beginning of the new year, insurance companies will develop unique promotion rhythms and marketing methods, launching a batch of savings-type insurance products with highlights such as "high returns," "safe financial management," and "stable cash flow" to attract consumers to purchase, increase market share, and aim to collect premiums at the beginning of the new year, setting a good tone for the whole year's business. However, there has been a subtle change in this work rhythm this year. The most direct impact is on social media platforms, as in previous years.
Hong Kong stocks are moving | New China Life Insurance has taken a stake in ah stocks, sh pharma (02607) rises over 4%.
sh pharma (02607) rose more than 4%, as of the deadline, rose by 2.01%, at 13.2 Hong Kong dollars, with a turnover of 16.3978 million Hong Kong dollars.
Return Trends At Shanghai Pharmaceuticals Holding (SHSE:601607) Aren't AppealingNo Data
No Data
